Evotec SE
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Latest news
All EVTA.F news ›Evotec (OTCMKTS:EVTCY) Stock Price Breaks Below Fifty Day Moving Average – Here’s What Happened
Posted by Defense World Staff on Oct 20th, 2026 Evotec SE (OTCMKTS:EVTCY – Get Free Report) crossed below its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $1.74 and traded as low as $1.38. Evotec…
Evotec fills CSO vacancy; Sibylla and AL-S Pharma name new CEOs
Every Friday, The Leadership Edit follows people taking new roles across European biotech and what their moves may tell us about the companies they join. This week: a swift scientific leadership change at Evotec, a broader reshuffle at…
Evotec names Dr. Joanna Holbrook as chief scientific officer
StreetInsider Evotec SE (NASDAQ: EVO) has appointed Dr. Joanna Holbrook as Chief Scientific Officer and member of its Management Board, effective November 1, 2026, according to a company statement. In her new role, Dr. Holbrook will…
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
15.10.2026 / 13:38 CET/CEST Legal entity: Government of Abu DhabiCity of registered office, country: Abu Dhabi, United Arab Emirates The stake was held indirectly by Mubadala Investment Company PJSC (“MIC”), which is wholly owned by the…
Evotec Appoints Dr. Joanna Holbrook as Chief Scientific Officer and Member of the Management Board
Ericsson reports third quarter results 2026 Evotec (EVO) appointed Dr. Joanna Holbrook as Chief Scientific Officer and Management Board member, effective November 1, 2026. Successor search was ongoing after CSO Cord Dohrmann's planned…
Evotec SE shareholder sells 11.5M shares in exit
A €2.5109-per-share block trade ends an investment in Evotec SE (EVO). Stock Titan - [SCHEDULE 13D/A] Evotec SE Amended Major Shareholder Report Evotec SE shareholder sells 11.5M shares in exit Three reporting persons ceased to be…
Evotec preliminary nine-month revenue near €465M
Evotec said preliminary nine-month 2026 figures exceeded market expectations and reaffirmed its full-year revenue and adjusted EBITDA guidance. Evotec SE (EVO) announced preliminary, unaudited Group revenue of approximately €465.0 million…
Ad hoc: Evotec announces preliminary nine-months 2026 results above market expectations, reaffirming full-year 2026 guidance
Evotec SE / Key word(s): Forecast / Other 13-Oct-2026 / 22:37 CET/CEST Hamburg, Germany – Evotec SE (NASDAQ: EVO; Frankfurt Prime Standard: EVT) today announced preliminary unaudited financial results for first nine months of 2026. Full…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
tradingview.com4
-
stocktitan.net3
-
european-biotechnology.com2
-
defenseworld.net1
-
streetinsider.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 12 articles, not a forecast.